Recent Analysts’ Ratings Changes for Molina Healthcare (MOH)

Molina Healthcare (NYSE: MOH) has recently received a number of price target changes and ratings updates:

• 6/23/2026 – Molina Healthcare is now covered by Royal Bank Of Canada. They set a “sector perform” rating and a $216.00 price target on the stock.
• 6/23/2026 – Molina Healthcare is now covered by Royal Bank Of Canada. They set a “sector perform” rating and a $216.00 price target on the stock.
• 6/8/2026 – Molina Healthcare was given a new $215.00 price target by Mizuho.
• 6/8/2026 – Molina Healthcare had its price target raised by JPMorgan Chase & Co. from $169.00 to $191.00. They now have a “neutral” rating on the stock.
• 6/4/2026 – Molina Healthcare had its price target raised by Morgan Stanley from $146.00 to $167.00. They now have an “equal weight” rating on the stock.
• 5/26/2026 – Molina Healthcare had its price target raised by Barclays PLC from $161.00 to $199.00. They now have an “underweight” rating on the stock.
• 5/22/2026 – Molina Healthcare had its price target raised by UBS Group AG from $180.00 to $202.00. They now have a “neutral” rating on the stock.
• 5/11/2026 – Molina Healthcare had its price target raised by Truist Financial Corporation from $180.00 to $205.00. They now have a “hold” rating on the stock.
• 5/11/2026 – Molina Healthcare had its price target raised by Cantor Fitzgerald from $144.00 to $209.00. They now have a “neutral” rating on the stock.
• 5/11/2026 – Molina Healthcare had its price target raised by Robert W. Baird from $124.00 to $163.00. They now have a “neutral” rating on the stock.
• 5/2/2026 – Molina Healthcare was upgraded by Wall Street Zen from “sell” to “hold”.
• 4/29/2026 – Molina Healthcare was upgraded by Bank of America Corporation from “underperform” to “buy”. They now have a $250.00 price target on the stock.
• 4/27/2026 – Molina Healthcare had its price target raised by Wells Fargo & Company from $141.00 to $159.00. They now have an “equal weight” rating on the stock.
• 4/27/2026 – Molina Healthcare had its price target raised by Truist Financial Corporation from $145.00 to $180.00. They now have a “hold” rating on the stock.

Insider Activity at Molina Healthcare

In other news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares in the company, valued at approximately $12,502,611. This represents a 20.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer directly owned 12,815 shares in the company, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their position. The SEC filing for this sale provides additional information. 1.44% of the stock is currently owned by corporate insiders.

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.